Article Details
Retrieved on: 2021-05-11 03:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Emerging therapies in the NMOSD market include BAT4406F (Bio-Thera Solutions), CRD1 / cladribine (Chord Therapeutics), Ravulizumab (Alexion ...
Article found on: www.digitaljournal.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here